Terminal-restriction fragment length polymorphism analysis of diversity of mucosa-associated microbiota in patients with Crohn's disease

National Medical Journal of China

Volumn 93, Issue 36, 2013, Pages 2884-2889

  Ran, Wen Bin ^a   Ouyang, Qin ^a   Shi, Wei ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Cluster analysis; Crohn disease; Finger print; In situ nick end labeling

Indexed keywords

ACTINOPHAGE; ARTICLE; BACTEROIDES; CLINICAL ARTICLE; CLUSTER ANALYSIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; FIRMICUTES; HUMAN; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROFLORA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PROTEOBACTERIA; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SHANNON WIENER INDEX;

CASE-CONTROL STUDIES; CLUSTER ANALYSIS; CROHN DISEASE; DNA, BACTERIAL; HUMANS; INTESTINAL MUCOSA; MICROBIOTA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 16S;

EID: 84886742916     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.36.010     Document Type: Article

References (20)

1. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 2011, 140: 1785-1794.
2. Bernstein C N, Fried M, Krabshuis J H, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis, 2010, 16: 112-124.
3. Abraham C, Cho J H. Inflammatory bowel disease. N Engl J Med, 2009, 361: 2066-2078.
4. 2012, 17: 763-781.
5. Colombel J F, Sandborn W J, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med, 2010, 362: 1383-1395.
6. Sepehri S, Kotlowski R, Bernstein C N, et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis, 2007, 13: 675-683.
7. Engebretson J J, Moyer C L. Fidelity of select restriction endonucleases in determining microbial diversity by terminal-restriction fragment length polymorphism. Appl Environ Microbiol, 2003, 69: 4823-4829.
8. Hayashi H, Takahashi R, Nishi T, et al. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J Med Microbiol, 2005, 54: 1093-1101.
9. Berg R D. The indigenous gastrointestinal microflora. Trends Microbiol, 1996, 4: 430-435.
10. Kohyama A, Ogawa H, Funayama Y, et al. Bacterial population moves toward a colon-like community in the pouch after total proctocolectomy. Surgery, 2009, 145: 435-447.
11. McGuckin M A, Eri R, Simms L A, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis, 2009, 15: 100-113.
12. Sartor R B. Microbial influences in inflammatory bowel diseases. Gastroenterology, 2008, 134: 577-594.
13. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis, 2009, 15: 653-660.
14. Guamer F. Role of intestinal flora in health and disease. Nutr Hosp, 2007, 22 Suppl 2: 14-19.
15. 2009: 1-151.
16. 2004: 213-277.
17. Ott S J, Musfeldt M, Wenderoth D F, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut, 2004, 53: 685-693.
18. Keyluck C J. Simpson diversity and the Shannon-Wiener index as special cases of a generalized entropy. Oikos, 2005, 109: 203-207.
19. Nishikawa J, Kudo T, Sakata S, et al. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol, 2009, 44: 180-186.
20. Frey J C, Angert E R, Pell A N. Assessment of biases associated with profiling simple, model communities using terminal-restriction fragment length polymorphism-based analyses. J Microbiol Methods, 2006, 67: 9-19.